[Non-invasive biomarkers of fibrosis for the screening of patients with metabolic steatopathy (NAFLD): a significant role for all biologists]

Ann Biol Clin (Paris). 2019 Apr 1;77(2):125-127. doi: 10.1684/abc.2019.1428.
[Article in French]
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biology
  • Biomarkers / analysis*
  • Biomarkers / metabolism
  • Biopsy
  • Blood Chemical Analysis
  • Female
  • Humans
  • Liver / metabolism
  • Liver / pathology
  • Liver Cirrhosis / blood
  • Liver Cirrhosis / diagnosis
  • Liver Cirrhosis / metabolism
  • Liver Cirrhosis / pathology
  • Male
  • Mass Screening / methods*
  • Medical Laboratory Personnel*
  • Middle Aged
  • Non-alcoholic Fatty Liver Disease / blood
  • Non-alcoholic Fatty Liver Disease / diagnosis*
  • Non-alcoholic Fatty Liver Disease / metabolism
  • Non-alcoholic Fatty Liver Disease / pathology
  • Professional Role*

Substances

  • Biomarkers